Sex Differences in Movement Disorders

Overview

Journal Nat Rev Neurol

Specialty Neurology

Date 2020 Jan 5

PMID 31900464

Citations 78

Authors

Sara Meoni

Antonella Macerollo

Elena Moro

Affiliations

Soon will be listed here.

Abstract

In a range of neurological conditions, including movement disorders, sex-related differences are emerging not only in brain anatomy and function, but also in pathogenesis, clinical features and response to treatment. In Parkinson disease (PD), for example, oestrogens can influence the severity of motor symptoms, whereas elevation of androgens can exacerbate tic disorders. Nevertheless, the real impact of sex differences in movement disorders remains under-recognized. In this article, we provide an up-to-date review of sex-related differences in PD and the most common hyperkinetic movement disorders, namely, essential tremor, dystonia, Huntington disease and other chorea syndromes, and Tourette syndrome and other chronic tic disorders. We highlight the most relevant clinical aspects of movement disorders that differ between men and women. Increased recognition of these differences and their impact on patient care could aid the development of tailored approaches to the management of movement disorders and enable the optimization of preclinical research and clinical studies.

Citing Articles

Sex differences in age-associated neurological diseases-A roadmap for reliable and high-yield research.

Bonkhoff A, Coughlan G, Perosa V, Alhadid K, Schirmer M, Regenhardt R Sci Adv. 2025; 11(10):eadt9243.

PMID: 40043111 PMC: 11881909. DOI: 10.1126/sciadv.adt9243.

Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrils.

Tullo S, Park J, Gallino D, Park M, Mar K, Novikov V Commun Biol. 2025; 8(1):288.

PMID: 39987244 PMC: 11846974. DOI: 10.1038/s42003-025-07680-1.

Second-generation antipsychotic-induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database.

Ebina T, Iwamoto K, Ando M, Ikeda M Psychiatry Clin Neurosci. 2025; 79(3):117-124.

PMID: 39834274 PMC: 11874247. DOI: 10.1111/pcn.13785.

Chronic Tic Disorders in Youth: Clinical Phenotypes and Response to Pharmacological Treatment with Aripiprazole.

Falcone F, Berloffa S, Sesso G, Narzisi A, Valente E, Viglione V Children (Basel). 2025; 11(12.

PMID: 39767888 PMC: 11674385. DOI: 10.3390/children11121459.

Disentangling the effect of sex from brain size on brain organization and cognitive functioning.

Brzezinski-Rittner A, Moqadam R, Iturria-Medina Y, Chakravarty M, Dadar M, Zeighami Y Geroscience. 2025; 47(1):247-262.

PMID: 39757311 PMC: 11872830. DOI: 10.1007/s11357-024-01486-5.

References

Ferretti M, Iulita M, Cavedo E, Chiesa P, Dimech A, Chadha A . Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018; 14(8):457-469. DOI: 10.1038/s41582-018-0032-9. View

Cordonnier C, Sprigg N, Sandset E, Pavlovic A, Sunnerhagen K, Caso V . Stroke in women - from evidence to inequalities. Nat Rev Neurol. 2017; 13(9):521-532. DOI: 10.1038/nrneurol.2017.95. View

Vetvik K, MacGregor E . Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2016; 16(1):76-87. DOI: 10.1016/S1474-4422(16)30293-9. View

Rabin M, Stevens-Haas C, Havrilla E, Devi T, Kurlan R . Movement disorders in women: a review. Mov Disord. 2013; 29(2):177-83. DOI: 10.1002/mds.25723. View

Smith K, Dahodwala N . Sex differences in Parkinson's disease and other movement disorders. Exp Neurol. 2014; 259:44-56. DOI: 10.1016/j.expneurol.2014.03.010. View

Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia M . The relevance of gender in Parkinson's disease: a review. J Neurol. 2017; 264(8):1583-1607. DOI: 10.1007/s00415-016-8384-9. View

Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark T, Frosch M . Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis. 2007; 26(3):606-14. PMC: 2435483. DOI: 10.1016/j.nbd.2007.02.009. View

Simunovic F, Yi M, Wang Y, Stephens R, Sonntag K . Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS One. 2010; 5(1):e8856. PMC: 2810324. DOI: 10.1371/journal.pone.0008856. View

Rijpkema M, Everaerd D, van der Pol C, Franke B, Tendolkar I, Fernandez G . Normal sexual dimorphism in the human basal ganglia. Hum Brain Mapp. 2011; 33(5):1246-52. PMC: 6870514. DOI: 10.1002/hbm.21283. View

10.

Xu J, Kobayashi S, Yamaguchi S, Iijima K, Okada K, Yamashita K . Gender effects on age-related changes in brain structure. AJNR Am J Neuroradiol. 2000; 21(1):112-8. PMC: 7976349. View

11.

Gillies G, Pienaar I, Vohra S, Qamhawi Z . Sex differences in Parkinson's disease. Front Neuroendocrinol. 2014; 35(3):370-84. PMC: 4096384. DOI: 10.1016/j.yfrne.2014.02.002. View

12.

Litim N, Morissette M, Di Paolo T . Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease. Neurosci Biobehav Rev. 2015; 67:79-88. DOI: 10.1016/j.neubiorev.2015.09.024. View

13.

Greene N, Lassen C, Rugbjerg K, Ritz B . Reproductive factors and Parkinson's disease risk in Danish women. Eur J Neurol. 2014; 21(9):1168-77, e68. DOI: 10.1111/ene.12450. View

14.

Liu R, Baird D, Park Y, Freedman N, Huang X, Hollenbeck A . Female reproductive factors, menopausal hormone use, and Parkinson's disease. Mov Disord. 2013; 29(7):889-96. PMC: 4057969. DOI: 10.1002/mds.25771. View

15.

Gatto N, Deapen D, Stoyanoff S, Pinder R, Narayan S, Bordelon Y . Lifetime exposure to estrogens and Parkinson's disease in California teachers. Parkinsonism Relat Disord. 2014; 20(11):1149-56. DOI: 10.1016/j.parkreldis.2014.08.003. View

16.

Strafella C, Caputo V, Galota M, Zampatti S, Marella G, Mauriello S . Application of Precision Medicine in Neurodegenerative Diseases. Front Neurol. 2018; 9:701. PMC: 6115491. DOI: 10.3389/fneur.2018.00701. View

17.

Goedert M, Spillantini M, Del Tredici K, Braak H . 100 years of Lewy pathology. Nat Rev Neurol. 2012; 9(1):13-24. DOI: 10.1038/nrneurol.2012.242. View

18.

Dickson D, Braak H, Duda J, Duyckaerts C, Gasser T, Halliday G . Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009; 8(12):1150-7. DOI: 10.1016/S1474-4422(09)70238-8. View

19.

Postuma R, Aarsland D, Barone P, Burn D, Hawkes C, Oertel W . Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord. 2012; 27(5):617-26. DOI: 10.1002/mds.24996. View

20.

Moore K, Boscardin W, Steinman M, Schwartz J . Age and sex variation in prevalence of chronic medical conditions in older residents of U.S. nursing homes. J Am Geriatr Soc. 2012; 60(4):756-64. PMC: 3387922. DOI: 10.1111/j.1532-5415.2012.03909.x. View